THIS SITE IS INTENDED
FOR US CONSUMERS

  • BEVESPI AEROSPHERE is a prescription medication used long-term to treat adults with COPD READ MORE...(chronic obstructive pulmonary disease), including chronic bronchitis, emphysema, or both. SHOW LESS
  • BEVESPI AEROSPHERE is not a rescue inhaler and is not for use to treat sudden COPD symptoms. READ MORE...It is not for use in asthma. SHOW LESS

HOW BEVESPI AEROSPHERE CAN HELP

twice-daily-icon

When taken as prescribed for COPD, BEVESPI AEROSPHERE can help improve your breathing starting at 5 minutes.*

BEVESPI AEROSPHERE will not replace a rescue inhaler for sudden COPD symptoms.

*Individual results may vary

TWO MEDICINES, ONE INHALER

BEVESPI AEROSPHERE contains two medicines, the LAMA glycopyrrolate and the LABA formoterol fumarate, that work in different ways to help relax the muscles around your airways. When taken long-term—2 puffs, 2 times a day—BEVESPI AEROSPHERE aims to open airways to the max.

BEVESPI AEROSPHERE is a pressurized metered dose inhaler (pMDI) that delivers each medicine to your lungs so they can have their effect. It is a long-term treatment that comes in the same type of inhaler as most rescue medications. Remember, BEVESPI AEROSPHERE is not for use to treat sudden COPD symptoms or for asthma.

 
 
 

HOW DOES BEVESPI AEROSPHERE HELP OPEN UP MY AIRWAYS?

The two medicines contained within BEVESPI AEROSPHERE are called bronchodilators.

One medicine helps relax the smooth muscles around the airways, and the other medicine helps prevent those muscles from tightening. The medicines can complement each other because they work in different ways.

Illustration of a normal airway compared to a narrowed airway

IMPORTANT SAFETY INFORMATION

  • BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased
  • BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma
  • Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms
  • Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE
  • Tell your healthcare provider about all the medicines you take and about all your health conditions
  • Do not use BEVESPI AEROSPHERE more often than prescribed
  • Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason
  • Call your healthcare provider or get medical care right away if:
    • Your breathing problems get worse
    • You need to use your rescue inhaler more often than usual or your rescue inhaler doesn’t work as well at relieving symptoms

BEVESPI AEROSPHERE can cause serious side effects, including:

  • Sudden breathing problems immediately after inhaling your medicine
  • Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems
  • Fast or irregular heartbeat, increased blood pressure, chest pain
  • Tremor or nervousness
  • New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose
  • New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away
  • High blood sugar or low blood potassium

Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away.

APPROVED USE

BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma.

Please read full Prescribing Information , including Patient Information and Instructions for Use .

IMPORTANT SAFETY INFORMATION

  • BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased

You may report side effects related to AstraZeneca products by clicking here.

USA flagThis site is intended for US Consumers only.

The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you.

X


BEVESPI_AEROSPHERE